Authorities in Abu Dhabi said Tuesday that a fire broke out at a facility in the Ruwais industrial complex following a drone attack, with no injuries reported so far.

BEIJING, March 10 (Xinhua) -- The remains of Song Ping, a former senior official of the Communist Party of China and the state, were cremated in Beijing on Tuesday.Xi Jinping, Li Qiang, Zhao Leji, Wang Huning, Cai Qi, Ding Xuexiang, Li Xi, Han Zheng and other leaders paid their final respects to Song at the Babaoshan Revolutionary Cemetery. Hu Jintao sent a wreath to express his condolences over Song's passing.Song died of illness in Beijing on March 4 at the age of 109.

BEIJING, March 10 (Xinhua) -- Chinese scientists have improved upon an existing powerful leukemia treatment, which now works even when cancer cells try to hide from it.Their innovative approach, detailed in the latest issue of the journal Cell, acts like a molecular bridge, strengthening the connection between the body's cancer-fighting cells and the leukemia cells they are meant to destroy.Their treatment modifies what is traditionally known as CAR T cell therapy. Such therapy involves taking a patient's T cells, changing them in a lab so they can find and attack cancer cells, and then putting them back into the patient's body.In many patients, however, the cancer comes back after the therapy. This happens because cancer cells can hide. They remove the marker on their surface that the CAR T cells are looking for. Once hidden, CAR T cells cannot find them.In the past, fixing this meant going back to the lab to genetically redesign the T cells all over again. This process is expensive, takes a long time, and is technically very difficult.Now, a research team from the Institute of Process Engineering (IPE) at the Chinese Academy of Sciences has developed a new helper molecule called FACE.The idea came from studying patient samples. The researchers found that both leukemia cells and the immune cells used in CAR T therapy have large amounts of the same protein on their surface -- a protein called CD71. So they created FACE from ferritin, a natural protein that binds to CD71. During the preparation process, FACE attaches to CAR T cells. Later, when those cells are given to the patient, FACE also grabs onto nearby leukemia cells, locking the two together.FACE serves as a tiny bridge or a piece of strong glue. Even when leukemia cells try to hide, FACE helps the CAR T cells hold on and do their job, said Wei Wei, one of the lead researchers from the IPE.The research results have been striking. In laboratory studies using mouse leukemia subjects, the new approach worked e...